[KYMR] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[KYMR] Kymera Therapeutics, Inc.
Announcement Date
10-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -15.90%
YoY- -257.90%
Quarter Report
KYMR's Result
KYMR's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 11,514 9,622 15,275 20,336 18,519 18,702 12,785 -6.76%
PBT -40,257 -36,684 -33,901 -28,582 -24,660 -13,075 -12,685 116.41%
Tax -553 -249 51 125 98 118 -373 30.11%
NP -39,704 -36,435 -33,901 -28,582 -24,660 -13,075 -12,685 114.42%
Tax Rate - - - - - - - -
Total Cost 51,218 46,057 49,176 48,918 43,179 31,777 25,470 59.52%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -344.83 -378.66 -221.94 -140.55 -133.16 -69.91 -99.22 129.96%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.77 -0.71 -0.66 -0.56 -0.55 -0.29 -0.29 92.09%
EPS Diluted -0.77 -0.71 -0.66 -0.56 -0.55 -0.29 -0.29 92.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.